Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series

Abstract Objective This retrospective case series aimed to provide initial insights into the potential effectsof Gemcitabine (Gem), Nab-paclitaxel, Ifosfamide, and Cisplatin (Gem-TIP) combination therapy in children with relapsed/progressive extracranial malignant rhabdoid tumors (eMRTs). Methods A...

Full description

Saved in:
Bibliographic Details
Main Authors: Jian Li, Lulu He, Tianjiao Hu, Xinrong Lin, Qian Zhao, Qiyang Shen, Jianfeng Zhou, Tao Li, Li Zhou
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13738-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849767166725849088
author Jian Li
Lulu He
Tianjiao Hu
Xinrong Lin
Qian Zhao
Qiyang Shen
Jianfeng Zhou
Tao Li
Li Zhou
author_facet Jian Li
Lulu He
Tianjiao Hu
Xinrong Lin
Qian Zhao
Qiyang Shen
Jianfeng Zhou
Tao Li
Li Zhou
author_sort Jian Li
collection DOAJ
description Abstract Objective This retrospective case series aimed to provide initial insights into the potential effectsof Gemcitabine (Gem), Nab-paclitaxel, Ifosfamide, and Cisplatin (Gem-TIP) combination therapy in children with relapsed/progressive extracranial malignant rhabdoid tumors (eMRTs). Methods A retrospective review of patients treated with Gem-TIP following relapse/progression was conducted. Radiologic responses were assessed using RECIST 1.1 criteria, with supplemental imaging data provided for detailed evaluation. Details of concurrent therapies, including radiotherapy, were documented to better delineate their influence on treatment outcomes. Results Ten patients were included, with a median age of 29.5 months at diagnosis. Tumor origins were predominantly renal (8 cases). Patients received a median of 3.1 cycles of Gem-TIP. The overall response rate (ORR) was 40% (1 CR, 3 PR), and the disease control rate (DCR) was 70%. Median event-free survival (EFS) and overall survival (OS) were 4 and 7.5 months, respectively. Radiotherapy and secondary surgery administered to 3 patients after Gem-TIP chemotherapy, likely contributed to improved local control. Toxicities included grade 4 neutropenia (50%) and thrombocytopenia (70%). However, limited data on hearing evaluation due to the retrospective design was noted. Conclusions Gem-TIP chemotherapy demonstrated preliminary evidence of therapeutic activity in relapsed/progressive eMRTs, but its role requires to be verified by large, prospective multi-center studies of rigorous design.
format Article
id doaj-art-cc2f5c9e02ef414a9b33deb50d784909
institution DOAJ
issn 1471-2407
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-cc2f5c9e02ef414a9b33deb50d7849092025-08-20T03:04:20ZengBMCBMC Cancer1471-24072025-02-012511910.1186/s12885-025-13738-4Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case seriesJian Li0Lulu He1Tianjiao Hu2Xinrong Lin3Qian Zhao4Qiyang Shen5Jianfeng Zhou6Tao Li7Li Zhou8Department of Oncology, Children’s Hospital of Nanjing Medical UniversityDepartment of Hematology, Children’s Hospital of Nanjing Medical UniversityDepartment of Pharmacy, Children’s Hospital of Nanjing Medical UniversityDepartment of Oncology, Children’s Hospital of Nanjing Medical UniversityDepartment of Oncology, Children’s Hospital of Nanjing Medical UniversityDepartment of Oncology, Children’s Hospital of Nanjing Medical UniversityDepartment of Oncology, Children’s Hospital of Nanjing Medical UniversityDepartment of Oncology, Children’s Hospital of Nanjing Medical UniversityDepartment of Oncology, Children’s Hospital of Nanjing Medical UniversityAbstract Objective This retrospective case series aimed to provide initial insights into the potential effectsof Gemcitabine (Gem), Nab-paclitaxel, Ifosfamide, and Cisplatin (Gem-TIP) combination therapy in children with relapsed/progressive extracranial malignant rhabdoid tumors (eMRTs). Methods A retrospective review of patients treated with Gem-TIP following relapse/progression was conducted. Radiologic responses were assessed using RECIST 1.1 criteria, with supplemental imaging data provided for detailed evaluation. Details of concurrent therapies, including radiotherapy, were documented to better delineate their influence on treatment outcomes. Results Ten patients were included, with a median age of 29.5 months at diagnosis. Tumor origins were predominantly renal (8 cases). Patients received a median of 3.1 cycles of Gem-TIP. The overall response rate (ORR) was 40% (1 CR, 3 PR), and the disease control rate (DCR) was 70%. Median event-free survival (EFS) and overall survival (OS) were 4 and 7.5 months, respectively. Radiotherapy and secondary surgery administered to 3 patients after Gem-TIP chemotherapy, likely contributed to improved local control. Toxicities included grade 4 neutropenia (50%) and thrombocytopenia (70%). However, limited data on hearing evaluation due to the retrospective design was noted. Conclusions Gem-TIP chemotherapy demonstrated preliminary evidence of therapeutic activity in relapsed/progressive eMRTs, but its role requires to be verified by large, prospective multi-center studies of rigorous design.https://doi.org/10.1186/s12885-025-13738-4Extracranial malignant rhabdoid tumorsGem-TIPChemotherapy
spellingShingle Jian Li
Lulu He
Tianjiao Hu
Xinrong Lin
Qian Zhao
Qiyang Shen
Jianfeng Zhou
Tao Li
Li Zhou
Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
BMC Cancer
Extracranial malignant rhabdoid tumors
Gem-TIP
Chemotherapy
title Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
title_full Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
title_fullStr Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
title_full_unstemmed Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
title_short Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series
title_sort gem tip as a salvage therapy for pediatric extracranial malignant rhabdoid tumors insights from a retrospective case series
topic Extracranial malignant rhabdoid tumors
Gem-TIP
Chemotherapy
url https://doi.org/10.1186/s12885-025-13738-4
work_keys_str_mv AT jianli gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT luluhe gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT tianjiaohu gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT xinronglin gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT qianzhao gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT qiyangshen gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT jianfengzhou gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT taoli gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries
AT lizhou gemtipasasalvagetherapyforpediatricextracranialmalignantrhabdoidtumorsinsightsfromaretrospectivecaseseries